Scientists Uncover How a Genetic Mutation Triggers Parkinson’s Disease

Parkinson’s Disease is a progressive brain disorder that starts with movement problems, such as tremors and stiffness, and later affects memory, thinking, and other functions. Some people develop the disease before the age of 50, a condition known as early-onset Parkinson’s, which is often caused by genetic mutations. Scientists have long known that mutations in a protein called PINK1 can lead to early-onset Parkinson’s, but until now, they didn’t fully understand why. A new study published in Science has shed light on how PINK1 mutations contribute to the disease. These findings could help researchers develop better treatments in the future. The Role of PINK1 in Cell Health Every cell in our body relies on tiny structures called mitochondria to generate energy—these are often referred to as the “powerhouses” of the cell. However, just like machines, mitochondria wear out over time and need to be removed and replaced. The PINK1 protein plays a key role in this process by identifying damaged mitochondria and tagging them for disposal. When mitochondria are damaged, PINK1 gathers on their surface and attaches a molecular tag called ubiquitin. This tag acts like a signal, telling the cell to get rid of the faulty mitochondria. Normally, this cleanup process helps keep brain cells healthy. What Happens When PINK1 Is Mutated? In people with early-onset Parkinson’s, mutations in the PINK1 gene prevent it from functioning properly. Without this signal, damaged mitochondria build up inside brain cells, particularly in neurons that produce dopamine—a chemical that helps control movement. As these neurons become overwhelmed with faulty mitochondria, they start to die off, leading to the movement issues seen in Parkinson’s Disease. This study is the first to reveal exactly how PINK1 attaches to mitochondria and activates the disposal process. Researchers found that multiple proteins work together to create a docking site for PINK1 on damaged mitochondria. Once attached, PINK1 links up with another protein, called Parkin, which helps recycle the damaged mitochondria. A Breakthrough for Future Treatments Dr. Sylvie Callegari, a senior researcher at the Walter and Eliza Hall Institute (WEHI), highlighted that this research also shows, for the first time, how mutations in Parkinson’s patients affect the way PINK1 functions. Professor David Komander, the study’s lead author, described the discovery as a “significant milestone” in Parkinson’s research. “Our findings reveal new ways to activate PINK1, which could be life-changing for people with Parkinson’s,” he said. With this new understanding, researchers are now working to develop drugs that could restore PINK1’s function in people with Parkinson’s, potentially slowing or even stopping the progression of the disease. This breakthrough brings hope for better treatments and, one day, a cure.